Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-43.99	44.02	78.60
Graham Fair Price	69.36	2.47	1.46
PEG	-91.98	0.07	-0.85
Price/Book	2.54	1.29	1.26
Price/Cash Flow	571.76	-253.30	37.71
Prices/Earnings	-65.12	15.96	45.74
Price/Sales	-9.31	2.85	3.15
Price/FCF	571.76	-253.30	37.71
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-9.89	0.17	0.19
Operating Margin	1251.48	0.05	< 0.005
ROA	197.20	< 0.005	< 0.005
ROE	< 0.005	0.02	193.96
ROIC	< 0.005	0.02	874.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.43	-0.16	160.29
Dividends QOQ	-0.86	-0.02	97.98
EBIT QOQ	-0.91	14.48	1493.33
EPS QOQ	-0.54	2.34	335.10
FCF QOQ	1.40	-1.15	-17.62
Revenue QOQ	-0.07	0.15	101.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	245.18	199.25	-18.73
Days Sales Outstanding (DSO)	301.68	225.99	-25.09
Inventory Turnover	0.37	0.45	23.05
Debt/Capitalization	0.15	0.20	32.80
Quick Ratio	0.79	0.76	-3.76
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.71	3.66	-1.22
Cash	1.57	1.75	11.95
Capex	-0.08	-0.04	55.55
Free Cash Flow	0.12	-0.02	-84.92
Revenue	1.48	1.65	11.68
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.19	1.23	3.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.14	-3.24	64.59
Naive Interpretation	Member

06 - Financial Health · Weak

Rating